# Milk-only Lactation Study for Patients on Eltrombopag

> **NCT01055600** · PHASE4 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Thrombocytopaenia

## Interventions

- **DRUG:** eltrombopag

## Key facts

- **NCT ID:** NCT01055600
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Protocol opened to recruitment in Nov 2009. No potential subjects identified in 5 years; therefore, study was terminated in Jul 2014 due to lack of feasibility
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055600, "Milk-only Lactation Study for Patients on Eltrombopag". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01055600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*